Participating in the Blue Cross Blue Shield Alliance for Health Research, Yale researchers accessed Blue Cross Blue Shield Axis®, the largest source of commercial insurance claims
Some types of state breast density notification laws lead to further screening and can modestly boost cancer detection rates, according to a new study released today by researchers at Yale’s School of Public Health and School of Medicine (Yale), which used commercial insurance claims data from Blue Cross and Blue Shield (BCBS) companies. Yale researchers analyzed the data to determine if various state laws, such as ones that mandate that doctors recommend further screening procedures or those that simply require doctors to disclose additional information about dense breast tissue, make a difference in the number of breast ultrasounds provided and in cancer detection rates. ... |